Refractory pure red cell aplasia associated with chronic lymphocytic leukemia successfully treated with ibrutinib - Goldschmidt, Neta; Rund, Deborah (Leukemia & lymphoma, 2017)
Keywords: Aged; Antineoplastic Agents - adverse effects; Antineoplastic Agents - therapeutic use; Biomarkers; Biopsy; Blood Cell Count; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell - complications; Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis; Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy; Protein Kinase Inhibitors - adverse effects; Protein Kinase Inhibitors - therapeutic use; Pyrazoles - adverse effects; Pyrazoles - therapeutic use; Pyrimidines - adverse effects; Pyrimidines - therapeutic use; Red-Cell Aplasia, Pure - diagnosis; Red-Cell Aplasia, Pure - etiology; Treatment Outcome